— Know what they know.
Not Investment Advice

ADIL NASDAQ

Adial Pharmaceuticals, Inc.
1W: -4.0% 1M: -35.9% 3M: +39.7% YTD: -32.5% 1Y: -56.2% 3Y: -94.3% 5Y: -99.9%
$4.12
-0.01 (-0.24%)
 
Weekly Expected Move ±14.6%
$3 $3 $4 $5 $5
NASDAQ · Healthcare · Biotechnology · Tech Score Sell · Power 35 · $10.8M mcap · 2M float · 14.27% daily turnover · Short 42% of daily vol

Supply Chain Overview

18 relationships
18
As Filer
counterparties named
0
As Counterparty
mentioned by others
4
Rel. Types
2021-07-09
Earliest Filing
2025-08-01
Latest Filing
investor: 6 partner: 4 acquirer: 4 target: 4

Counterparties (Filed by ADIL)

18 relationships

Companies named in ADIL's SEC 8-K filings as business counterparties.

Counterparty Ticker Relationship Summary Filing Date SEC
A.G.P./Alliance Global Partners — partner Sales agent for ATM sales agreement 2025-08-01 View
H.C. Wainwright & Co., LLC — partner Former sales agent for terminated ATM sales agreement 2025-08-01 View
A.G.P./Alliance Global Partners — partner Placement agent for the best efforts offering of common stock and warrants. 2025-06-18 View
Alumni Capital LP — investor Investment agreement to purchase up to $10,000,000 of common stock over time 2024-12-18 View
H.C. Wainwright & Co., LLC — partner Sales Agent for the At the Market Offering Agreement 2024-04-18 View
Adial Pharmaceuticals, Inc. ADIL acquirer Filed 8-K regarding asset sale agreement 2023-09-21 View
Adovate, LLC — target Acquired assets and business of Purnovate, Inc. 2023-09-21 View
Purnovate, Inc. — target Assets and business sold to Adovate, LLC 2023-09-21 View
Purnovate, Inc. — target Assets and business sold to Adovate 2023-08-18 View
Adovate, LLC — acquirer Acquired assets and business of Purnovate 2023-08-18 View
Adenomed, LLC — acquirer Former name of Adovate, LLC 2023-08-18 View
Alumni Capital LP — investor Investment agreement for the sale of up to $10,000,000 of common stock and issuance of commitment shares. 2023-06-02 View
Adovate, LLC — acquirer Adovate exercised an option to acquire all assets and business of Purnovate, Inc. 2023-05-10 View
Purnovate, Inc. — target Target of the asset acquisition by Adovate, LLC. 2023-05-10 View
Bespoke Growth Partners, Inc. — investor Purchased up to 200,000 shares of common stock for $800,000 under a Securities Purchase Agreement. 2021-11-12 View
Bespoke Growth Partners, Inc. — investor Pre-existing investor purchasing common stock in private placement 2021-07-09 View
Keystone Capital Partners, LLC — investor Pre-existing investor purchasing common stock in private placement 2021-07-09 View
Cumberland Resources — investor Entity associated with investor Richard Gilliam purchasing common stock 2021-07-09 View
Recent 8-K Filings (20)
Filing Date Description Type SEC
2026-10-02 Other Events View
2026-09-18 Officer/Director Change; Shareholder Vote; Exhibits View
2026-09-16 Material Agreement; Other Events; Exhibits Agreement View
2026-08-25 Unregistered Equity Sales View
2026-08-21 Delisting Notice View
2026-08-17 Earnings Release; Exhibits View
2026-08-13 Officer/Director Change; Other Events View
2026-08-11 Exhibits View
2026-06-11 Material Agreement; Acquisition/Disposition; Financial Obligation; Unregistered Equity Sales; Office Agreement Acquisition View
2026-04-09 Officer/Director Change; Exhibits View
2026-03-06 Results of Operations and Financial Condition; Financial Statements and Exhibits View
2026-03-03 Regulation FD Disclosure; Other Events; Financial Statements and Exhibits View
2026-02-24 Other Events; Financial Statements and Exhibits View
2026-02-04 Material Modification to Rights of Security Holders; Amendments to Articles of Incorporation or Byla View
2026-01-06 Departure/Election of Directors; Appointment of Officers View
2025-12-01 Entry into Material Definitive Agreement; Unregistered Sales of Equity Securities; Other Events; Fin Agreement View
2025-11-14 Results of Operations and Financial Condition; Financial Statements and Exhibits View
2025-09-16 Regulation FD Disclosure; Other Events; Financial Statements and Exhibits View
2025-09-03 Notice of Delisting or Transfer; Financial Statements and Exhibits View
2025-08-14 Results of Operations and Financial Condition; Financial Statements and Exhibits View
Data extracted from SEC EDGAR 8-K filings using NLP. Relationships are as disclosed in filing text. Covers 2021–2026. View on SEC EDGAR

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms